Skip to content

Acupuncture for poor ovarian response: a randomized controlled trial

Acupuncture for poor ovarian response: a randomized controlled trial

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017717
Enrollment
Unknown
Registered
2018-08-01
Start date
2018-08-01
Completion date
Unknown
Last updated
2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

poor ovarian response

Interventions

Experiment Group:acupuncture + COH
Control group:COH

Sponsors

Institute of acupuncture and moxibustion, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
35 Years to 40 Years

Inclusion criteria

Inclusion criteria: (1) according to the diagnostic criteria of POR; (2) having IVF or Intracytoplasmic sperm injection (ICSI) for gestational indications; (3) Aged 35 to 40 years old.

Exclusion criteria

Exclusion criteria: (1) patients with recurrent spontaneous abortion more than 2 times (including biochemical abortion); (2) Repeated implantation failure (at least 3-6 high-quality embryos transplanted without clinical pregnancy after at least 3 transplantation cycles); (3) the patients with uterine malformation (single angle uterus, double horned uterus, double uterus, untreated mediastinal uterus) and other patients with endometriosis (adenomyosis, submucous hysteromyoma, intrauterine adhesion and scar uterus); (4) patients and their husbands had abnormal karyotype (excluding chromosome polymorphism); (5) untreated patients with hydrosalpinx; (6) a contraindication of ART and pregnancy, or a patient with a definite influence on pregnancy, such as hypertension, heart disease with clinical symptoms, diabetes, liver disease, kidney disease, severe anemia, venous thrombosis, pulmonary embolism or history of cerebral vascular events, and malignant swelling of the tumor; (7) Ovarian dysfunction caused by iatrogenic factors (such as pelvic surgery, radiotherapy and chemotherapy, uterine artery embolism, drugs such as hormones, immunosuppressants, etc.); (8) refusing to sign a letter of informed consent.

Design outcomes

Primary

MeasureTime frame
Number of retrieved oocytes;

Secondary

MeasureTime frame
Fertilization rate;Cleavage rate;embryo implantation rate;Utilization of embryo rate;embryo implantation rate;Cycle pregnancy r;Antral follicle count;AMH;AMH;Basal hormone level;Menstrual condition;Self-RatingAnxietyScale;

Countries

China

Contacts

Public ContactYigong Fang

Institute of acupuncture and moxibustion, China Academy of Chinese Medical Sciences

fangyigong@163.com+86 13520175177

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 28, 2026